• Heptamethine Cyanine Dye Targets Progesterone Receptor in HR

  2026-04-16

  This study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye, as a novel agent capable of selectively suppressing progesterone receptor activity in hormone receptor-positive breast cancer. By inducing Golgi fragmentation and promoting immunogenic cell death, CA800-PR demonstrates therapeutic efficacy distinct from traditional hormone therapies, with potential implications for overcoming resistance in HR+ breast cancer.

• Oligomycin A: Benchmark Mitochondrial ATP Synthase Inhibitor

  2026-04-15

  Oligomycin A is a gold-standard mitochondrial ATP synthase inhibitor, blocking ATP production by targeting the F0 subunit proton channel. Its use in mitochondrial bioenergetics research enables precise dissection of oxidative phosphorylation and metabolic adaptation in cancer. APExBIO’s A5588 product offers robust, reproducible inhibition for advanced cell metabolism studies.

• Iron Stress Alters Enterocyte Metabolism and Inflammation

  2026-04-14

  Navazesh and Ji (2025) demonstrate that both iron deficiency and excess profoundly reprogram metabolic and inflammatory pathways in IPEC-J2 enterocytes. Using pharmacological iron modulation and untargeted metabolomics, the study reveals distinct metabolic signatures and gene expression shifts under iron stress, informing future research on intestinal health and iron homeostasis.

• YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol: Appli

  2026-04-13

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol enables precise inhibition of hypoxia-inducible factor 1 transcriptional activity, unlocking new avenues for apoptosis and cancer biology research. This article provides actionable workflows, troubleshooting insights, and a data-driven perspective on leveraging YC-1 in tumor angiogenesis and hypoxia assays.

• iPSC-Based CF Drug Testing: Innovations in Functional Airway

  2026-04-12

  This study establishes a robust induced pluripotent stem cell (iPSC) platform for modeling cystic fibrosis (CF) airway dysfunction and drug response. By adapting functional assays to iPSC-derived airway cells, the research enables precise evaluation of genotype-specific responses to CFTR modulators, offering new avenues for studying rare CFTR variants and accelerating therapeutic development.

• Branched Endosomal Disruptor Lipids Advance mRNA Delivery Ef

  2026-04-12

  This study introduces a new class of branched ionizable lipids (BEND) that substantially improve the delivery of mRNA and CRISPR-Cas9 RNPs by promoting endosomal escape. These findings have direct implications for enhancing hepatic gene editing and T cell engineering, highlighting the importance of ionizable lipid architecture in non-viral delivery systems.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Osteo

  2026-04-11

  Bazedoxifene offers researchers a third-generation, high-affinity SERM for dissecting estrogen receptor signaling and bone mineral density enhancement in postmenopausal osteoporosis models. Its tissue-selective antagonism and well-characterized pharmacology deliver robust, reproducible results for both mechanism-focused and translational workflows.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Fluores

  2026-04-11

  Leverage the Cy5 Goat Anti-Mouse IgG (H+L) Antibody for unparalleled sensitivity and robust signal amplification in immunohistochemistry and immunocytochemistry. Discover protocol optimizations, troubleshooting insights, and cross-domain innovations that elevate your fluorescent detection workflows.

• PR-619: Advanced Strategies for Deubiquitinase Inhibition...

  2026-04-10

  Explore PR-619, a broad-spectrum reversible DUB inhibitor, and its role in dissecting the ubiquitin-proteasome system for advanced cancer and neurodegeneration research. This article provides new insight into cysteine-dependent DUB inhibition and positions PR-619 as a cornerstone for next-generation ubiquitination and autophagy pathway analysis.

• 3X (DYKDDDDK) Peptide: Next-Gen Epitope Tag for Protein P...

  2026-04-09

  Discover the advanced applications of the 3X (DYKDDDDK) Peptide in recombinant protein purification and structural studies. This in-depth article explores its unique biochemical properties, mechanisms, and advantages over conventional epitope tags, offering new insights beyond current literature.

• 4-Ethylphenyl Sulfate: Uremic Toxin Biomarker & Neurobeha...

  2026-04-08

  4-Ethylphenyl sulfate is a validated microbiota-derived metabolite and uremic toxin biomarker with distinct roles in renal dysfunction and neurobehavioral modulation. This article details its mechanistic underpinnings, adsorption dynamics, and translational value for gut microbiota-brain interaction research. APExBIO’s high-purity B6051 reagent facilitates reproducible studies in both renal and autism spectrum disorder models.

• Verteporfin: Unraveling Mechanisms and Frontiers in Photo...

  2026-04-08

  Explore the molecular intricacies of Verteporfin, a potent photosensitizer for photodynamic therapy, as we dissect its dual roles in ocular neovascularization and autophagy inhibition. This article delivers a unique, mechanistic perspective anchored in cutting-edge gene regulation research, setting it apart from standard assay-focused content.

• Translational Power of 2-NBDG: Mechanistic Insights and S...

  2026-04-07

  Explore how the fluorescent glucose analog 2-NBDG is revolutionizing glucose metabolism research, with mechanistic depth, strategic assay design guidance, and direct translation to neurodegeneration, diabetes, cancer, and beyond. This thought-leadership article contextualizes 2-NBDG within the evolving metabolic landscape, highlights recent breakthroughs, and charts a course for next-generation translational studies.

• Thiothixene (C8719): Advancing Macrophage Efferocytosis A...

  2026-04-07

  This article delivers scenario-driven, evidence-based insights into deploying Thiothixene (SKU C8719) for reliable macrophage efferocytosis and cytotoxicity workflows. Drawing on recent peer-reviewed data and validated protocols, it addresses critical laboratory challenges—including reproducibility, protocol optimization, and product selection—empowering researchers to achieve robust, interpretable results with Thiothixene.

• Bay 11-7821 (BAY 11-7082): Unveiling New Frontiers in NF-...

  2026-04-06

  Explore how Bay 11-7821 (BAY 11-7082), a potent IKK and NF-κB pathway inhibitor, is advancing inflammatory signaling pathway research and cancer immunotherapy. This article offers a unique, mechanistic deep dive—connecting NF-κB inhibition with novel immune modulation strategies and translational applications.

447 records 21/30 page Previous Next First page 上5页 2122232425 下5页 Last page